Srilakshmi Yalavarthi et al.
Arthritis & rheumatology (Hoboken, N.J.), 67(11), 2990-3003 (2015-06-23)
Antiphospholipid antibodies (aPL), especially those targeting β2 -glycoprotein I (β2 GPI), are well known to activate endothelial cells, monocytes, and platelets, with prothrombotic implications. In contrast, the interaction of aPL with neutrophils has not been extensively studied. Neutrophil extracellular traps